Appointment booking for Dr. Daniel Macmillan, MD is currently not available.Dr. Daniel Macmillan, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Daniel Macmillan, MD (he/him) is a Surgeon in Jeffersonville, IN with over 19 years of experience. What is your opinion of Dr. Daniel Macmillan, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Daniel Macmillan, MD has received over $1,921 which includes payments from the following companies:
$488.39 from Ethicon US, LLC
$486.40 from Davol Inc.
$254.20 from LifeCell Corporation
$163.10 from Allergan Inc.
$69.33 from Actavis Pharma Inc
$57.76 from TELA Bio, Inc.
$46.61 from FOREST PHARMACEUTICALS, INC.
$41.44 from HALYARD HEALTH, INC.
$36.02 from Covidien LP
$30.41 from ACell, Inc.
$29.45 from Shire North American Group Inc
$24.40 from The Medicines Company
$22.79 from Merck Sharp & Dohme Corporation
$22.72 from Pfizer Inc.
$22.36 from Genentech USA, Inc.
$20.64 from Intuitive Surgical, Inc.
$19.25 from Molnlycke Health Care US, LLC
$19.04 from TEI Biosciences Inc
$18.94 from APOLLO ENDOSURGERY INC
$17.37 from Melinta Therapeutics, Inc.
Payments received by Dr. Daniel Macmillan, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!